Patient Guide: Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 245 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06731478
Status: 🟢 Enrolling Now
Condition: Gastric Cancer, Gastroesophageal Junction Cancer
Phase: PHASE3

Where You Can Participate

This study is available at 245 locations across the country.

Top locations include:
  • • New Haven, Connecticut
  • • Skokie, Illinois
  • • Kansas City, Kansas
  • • And 242 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer - Join Clinical Trial NCTNCT06731478

How to Join This Clinical Trial - NCTNCT06731478

Learn how to participate in this PHASE3 trial studying an investigational therapy for Gastric Cancer, Gastroesophageal Junction Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Gastric Cancer, Gastroesophageal Junction Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Gastric Cancer, Gastroesophageal Junction Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06731478 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 245 locations. Find a study site near you:

Clinical Research Site

New Haven, Connecticut 06520-8028 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Skokie, Illinois 60077 - United States

Status: RECRUITING

Clinical Research Site

Kansas City, Kansas 66160 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Silver Spring, Maryland 20904 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Boston, Massachusetts 02111 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Ann Arbor, Michigan 48109 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Minneapolis, Minnesota 55407 - United States

Status: WITHDRAWN

Clinical Research Site

New York, New York 10065 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

The Bronx, New York 10467 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Portland, Oregon 97213 - United States

Status: NOT_YET_RECRUITING

And 235 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Gastric Cancer, Gastroesophageal Junction Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships